LAVA Therapeutics (LVTX) EBITDA (2024 - 2025)
LAVA Therapeutics (LVTX) EBITDA from Mar 31, 2024 to Sep 30, 2025. The TTM LAVA Therapeutics (LVTX) EBITDA is -$30M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
LAVA Therapeutics (LVTX) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +37.01% |
Annual EBITDA change of LAVA Therapeutics (LVTX)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$23M | -20.53% |
| 2024 | -$29M | -31.67% |
| 2023 | -$43M | +35.12% |
| 2022 | -$32M | -23.84% |
| 2021 | -$42M | +167.50% |
| 2020 | -$16M | N/A |